Europe's medicines regulator on Monday approved the use of the COVID-19 vaccine developed by U.S. company Pfizer and its German partner BioNTech, putting the EU on course to start inoculations just after Christmas.
Commission President Ursula von der Leyen said doses would be available for all EU countries, at the same time and on the same conditions. EMA officials said it was highly likely the vaccine would work against the new variant of the coronavirus. A phased-in approach means frontline healthcare workers and elderly residents of care homes are being prioritised, with most national schemes not reaching the general public until the end of the first quarter of 2021 at the earliest.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: